Berry Genomics (000710.SZ) released its first quarter financial results with a net loss attributable to shareholders of 6.4622 million yuan.

Financial News APP updates, Berry Genomics (000710.SZ) released its first quarter report for 2025. In the first quarter, the company achieved operating revenue of 218 million yuan, a year-on-year decrease of 22.08%. The net loss attributable to shareholders of the listed company was 6.4622 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 3.6827 million yuan.